Wolverine Asset Management’s Aimei Health Technology Co AFJK Stock Holding History

Wolverine Asset Management’s Portfolio AFJK Stock Details AFJK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-401,754	Closed	-$4.55M	–	1653
2025 Q3	$4.55M	Sell	401,754 -3,003	-0.7%	-$33.8K	0.03%	366
2025 Q2	$4.48M	Sell	404,757 -3,042	-0.7%	-$33.7K	0.04%	353
2025 Q1	$4.48M	Sell	407,799 -246,240	-38%	-$2.67M	0.05%	320
2024 Q4	$7M	Buy	654,039 +115,000	+21%	+$1.22M	0.07%	257
2024 Q3	$5.65M	Buy	539,039 +42,843	+9%	+$447K	0.06%	280
2024 Q2	$5.14M	Buy	496,196 +40,598	+9%	+$418K	0.06%	284
2024 Q1	$4.67M	Buy	+455,598	New	+$4.64M	0.05%	297

Other funds holding AFJK

First Trust Capital Management Chicago, Illinois $2.08B AUM 59.2% 1-Year Est. Return

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wolverine Asset Management's AFJK Position: Q4 2025 in Review

Wolverine Asset Management sold out of Aimei Health Technology Co (AFJK) in Q4 2025, closing a stake of 401,754 shares — an estimated $4.55M sold.

Wolverine Asset Management first reported a position in AFJK in Q1 2024 and held it in 7 quarters. The position peaked at $7M in Q4 2024. 11 funds tracked by Wall St. Rank hold AFJK as of Q4 2025.

Wolverine Asset Management reported no remaining Aimei Health Technology Co position as of Q4 2025 after selling out during the quarter.
Wolverine Asset Management sold 401,754 Aimei Health Technology Co shares in Q4 2025, an estimated $4.55M.
Wolverine Asset Management first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 7 quarters.
Wolverine Asset Management's Aimei Health Technology Co position peaked at $7M in Q4 2024.
11 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.